SCHEMBL684769

SCHEMBL684769

Cc1cccc(C(=O)N/N=C/c2ccc(Cl)cc2O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.66
RAB9A P51151 6/20 0.59
NPC1 O15118 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
MAPT P10636 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
PIK3CG P48736 1/20 0.56
KMT2A Q03164 5/20 0.55
LMNA P02545 4/20 0.55
MEN1 O00255 4/20 0.55
HTT P42858 3/20 0.55
KDM4E B2RXH2 3/20 0.55
POLB P06746 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
KLF5 Q13887 1/20 0.54
AGTR1 P30556 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569253 0.90 PIK3CG (0.69) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL684997 0.90 PIK3CG (0.69) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL6569257 0.90 PIK3CG (0.69) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL15127234 0.90 PIK3CG (0.61) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL684219 0.90 KDM1A (0.81) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL20175461 0.88 SIRT1 (0.64) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL685016 0.86 MAPT (0.66) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL684659 0.86 KDM1A (0.70) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL684774 0.85 RAB9A (0.80) KDM1ARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL21252762 0.85 RAB9A (0.64) KDM1ARAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791298-B2 Use of metal hydrazide complex compounds as oxidation catalysts BASF SE (DE) 2014-07-29 US disclosed
US-8715745-B2 Fungicidal compositions including hydrazone derivatives and copper DOW AGROSCIENCES, LLC. (US) 2014-05-06 US disclosed
US-8715745-B2 Fungicidal compositions including hydrazone derivatives and copper DOW AGROSCIENCES, LLC. (US) 2014-05-06 US disclosed
US-20130281353-A1 Use of Metal Hydrazide Complex Compounds as Oxidation Catalysts BASF SE (DE) 2013-10-24 US disclosed
US-8492324-B2 Use of metal hydrazide complex compounds as oxidation catalysts BASF SE (DE) 2013-07-23 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120009274-A1 FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120009274-A1 FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, SOD3 KDM1A 484/4885RAB9A 3846/4885NPC1 1690/4885
US-20120009274-A1 FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, CYP4Z1 KDM1A 291/4885RAB9A 3616/4885NPC1 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.